Menopause Hormone Therapy (HRT) in Long Beach, CA

Bioidentical hormones in Long Beach: what it means

If you are one of the 58,414 women aged 45 to 64 in Long Beach and have searched for "bioidentical" hormones: the word means a hormone whose structure matches one the body makes. Estradiol, the main estrogen the ovaries make before menopause, and micronized progesterone both fit that description. Both come in FDA-approved prescription forms, from estradiol pills, patches, gels and vaginal forms to progesterone capsules.

Many products sold as "bioidentical hormones" or "BHRT" are compounded instead: mixed by a pharmacy for one prescription, often as a custom cream or a pellet. They are not FDA-approved, which means the FDA cannot assure their safety or effectiveness. In the FDA's words, it has no evidence that compounded "bioidentical hormones" are safe and effective. A 2020 National Academies review found no rigorous evidence of their safety and effectiveness.

Long Beach has 86 OB-GYNs in the federal NPI registry, 18.8 per 100,000 residents, close to the US rate of 17.8 and above California's 16.9. That is about 680 women aged 45 to 64 for each OB-GYN in the city, a ratio rather than a count of open appointments.

Within 10 miles of the city there are 256 OB-GYNs, and within 25 miles 1,561, about 17.9 per 100,000 of the 8,718,742 residents in that radius. None of this replaces your own OB-GYN or a menopause doctor you trust; VevaMD adds an online route, with a physician licensed in California reviewing your answers from home in Long Beach.

For women in Long Beach, a physician licensed in California can prescribe estradiol (pill, patch, cream or vaginal) and progesterone when they fit your history. VevaMD does not offer pellets. Because the dispensing pharmacy also compounds, you can ask whether your estradiol or progesterone is an FDA-approved product. Testosterone cream for women and Bi-Est are compounded and not FDA-approved.

Then there are pellets, implanted under the skin at a clinic; compounded pellets are not FDA-approved. The Endocrine Society cites blood levels well above the expected range in women using compounded pellets. ACOG advises FDA-approved hormone therapy over compounded preparations.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11